Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 14;5(7):3624-3637.
doi: 10.1021/acsomega.9b04142. eCollection 2020 Feb 25.

Multispectroscopic and Computational Analysis Insight into the Interaction of Cationic Diester-Bonded Gemini Surfactants with Serine Protease α-Chymotrypsin

Affiliations

Multispectroscopic and Computational Analysis Insight into the Interaction of Cationic Diester-Bonded Gemini Surfactants with Serine Protease α-Chymotrypsin

Mohd Akram et al. ACS Omega. .

Abstract

Accumulation of different protein-surfactant mixtures affords further knowledge about the structure-property interactions of biomacromolecules. They will help design suitable surfactants, which, in turn, can enhance the utilization of protein-surfactant complexes in biotechnologies, cosmetics, and food industry realms. Owing to their adaptable and remarkably notable properties, we are describing herein the interaction of C m -E2O-C m gemini surfactants (m = 12, 14, and 16) with α-CHT by employing various spectroscopic techniques including with molecular docking and density functional theory (DFT) method. Results have revealed complex formation, unfolding, and a static quenching mechanism in the interaction of gemini surfactants with α-CHT. The Stern-Volmer constant (K SV), quenching constant (k q), the number of binding sites (n), and binding constant (K b) were interrogated by utilizing the fluorescence quenching method, UV-vis, synchronous, 3-D, and resonance Rayleigh scattering fluorescence studies. The data perceive the α-CHT-C m -E2O-C m complex formation along with conformational alterations induced in α-CHT. The contribution of aromatic residues to a nonpolar environment is illustrated by pyrene fluorescence. Fourier transform infrared spectroscopy and circular dichroism outcomes reveal conformational modifications in the secondary structure of α-CHT with the permutation of gemini surfactants. The computational calculations (molecular docking and DFT) further corroborate the complex formation between α-CHT and C m -E2O-C m gemini surfactants and the contribution of electrostatic/hydrophobic interaction forces therein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Chemical Structures of Cationic Cm-E2O-Cm Gemini Surfactants (m = (a) 12, (b) 14, and (c) 16) and (d) Crystallographic Structure of α-Chymotrypsin
Figure 1
Figure 1
UV–vis absorption spectra of α-CHT in the presence of Cm-E2O-Cm (m = (a) 12, (b) 14, and (c) 16) gemini surfactants (pH 7.8) at 298 K.
Figure 2
Figure 2
Synchronous fluorescence spectra of α-CHT (2 μM) with different concentrations of Cm-E2O-Cm (m = 12, 14, and 16) at (a–c) Δλ = 20 nm for Tyr and (d–f) Δλ = 60 nm for Trp at 298 K (pH 7.8).
Figure 3
Figure 3
Variation of micropolarity around pyrene as a function of Cm-E2O-Cm (m = (a) 12, (b) 14, and (c) 16) gemini surfactants at 298 K (pH 7.8).
Figure 4
Figure 4
FT-IR spectra of α-CHT (2 μM) in the absence and presence of 0.0867 mM Cm-E2O-Cm (m = 12, 14, and 16) gemini surfactants at 298 K (pH 7.8).
Figure 5
Figure 5
Three-dimensional (3-D) fluorescence spectra of (a) α-CHT (2 μM) in the absence and presence of 2.459 μM Cm-E2O-Cm (m = (b) 12, (c) 14, and (d) 16) gemini surfactants and (e) bar diagram at 298 K (pH 7.8).
Figure 6
Figure 6
CD spectra of α-CHT (40 μM) in the absence and presence of Cm-E2O-Cm (m = (a) 12, (b) 14, and (c) 16) gemini surfactants and (d) bar diagram at 298 K (pH 7.8).
Figure 7
Figure 7
Fluorescence emission spectra of α-CHT in the presence of Cm-E2O-Cm (m = (a) 12, (b) 14, and (c) 16) gemini surfactants at 298 K and pH 7.8.
Figure 8
Figure 8
Stern–Volmer plots for the binding of α-CHT with Cm-E2O-Cm (m = 12, 14, and 16) gemini surfactants at 298 K (pH 7.8).
Figure 9
Figure 9
Plots of log(F0F)/F versus log[Cm-E2O-Cm] for quenching of α-CHT by Cm-E2O-Cm (m = 12, 14, and 16) gemini surfactants; [α-CHT] = 2 μM; [Cm-E2O-Cm] = 0.0049–0.0867 mM at 298 K and pH 7.8.
Figure 10
Figure 10
Docking pose of the α-CHT complexed with (a) C12-E2O-C12, (b) C14-E2O-C14, and (c) C16-E2O-C16 gemini surfactants.
Figure 11
Figure 11
Binding sites of α-CHT with (a) C12-E2O-C12, (b) C14-E2O-C14, and (c) C16-E2O-C16 gemini surfactants.
Figure 12
Figure 12
Electrostatic potential map representing the electrostatic potential strength of (a) gemini surfactant (C12-E2O-C12) and (b) Trp and (c) Tyr residues of α-CHT.
Figure 13
Figure 13
Optimized HOMO and LUMO configurations/energy gaps of the gemini surfactants and Trp and Tyr residues obtained via DFT calculations.

Similar articles

Cited by

References

    1. Mahmoudi M.; Lynch I.; Ejtehadi M. R.; Monopoli M. P.; Bombelli F. B.; Laurent S. Protein–Nanoparticle Interactions: Opportunities and Challenges. Chem. Rev. 2011, 111, 5610–5637. 10.1021/cr100440g. - DOI - PubMed
    1. Lynch I.; Dawson K. A. Protein-Nanoparticle Interactions. Nano Today 2008, 3, 40–47. 10.1016/S1748-0132(08)70014-8. - DOI
    1. Akram M.; Anwar S.; Kabir-ud-Din Biophysical Investigation of Promethazine Hydrochloride Binding with Micelles of Biocompatible Gemini Surfactants: Combination of Spectroscopic and Electrochemical Analysis. Spectrochim. Acta, Part A 2019, 215, 249–259. 10.1016/j.saa.2019.02.082. - DOI - PubMed
    1. Sekhon B. S. Surfactants: Pharmaceutical and Medicinal Aspects. J. Pharm. Technol. Res. Manage. 2013, 1, 43–68. 10.15415/jptrm.2013.11004. - DOI
    1. Li P.; Nielsen H. M.; Fano M.; Müllertz A. Preparation and Characterization of Insulin–Surfactant Complexes for Loading into Lipid-Based Drug Delivery Systems. J. Pharm. Sci. 2013, 102, 2689–2698. 10.1002/jps.23640. - DOI - PubMed